CompanyGraph
Measures spending on new products, technologies, and improvements, exposing the company's investment rate in future capabilities versus current operations.
Research and development expenses represent money spent on developing new products, technologies or improvements. High R&D can support future growth but reduces current profit.
Research and development (R&D) expense represents spending on activities aimed at creating new products, improving existing offerings, developing new technologies, and advancing scientific knowledge. This investment in innovation appears as an operating expense on the income statement, reducing current profits but potentially creating future competitive advantages and revenue streams.
What R&D includes:
- Basic research: Fundamental scientific investigation
- Applied research: Directed toward specific practical applications
- Product development: Creating new products or features
- Process improvement: Enhancing manufacturing or delivery methods
- Clinical trials: Testing for pharmaceuticals and medical devices
Accounting treatment:
- US GAAP: Most R&D expensed as incurred (except software development after feasibility)
- IFRS: Development costs may be capitalised if certain criteria are met
Why R&D matters:
- Future growth: Today's R&D drives tomorrow's products and revenue
- Competitive position: Innovation maintains or improves market standing
- Moat building: Patents and proprietary technology create barriers
- Industry necessity: Many sectors require continuous R&D to survive
Analysing R&D spending:
- R&D as % of revenue: Shows innovation intensity; compare to peers
- R&D per employee: Measures investment in innovation capacity
- R&D productivity: Revenue growth relative to R&D spending over time
- Trend analysis: Increasing or decreasing investment rate?
Industry context:
- Pharmaceuticals: 15-25% of revenue typical; essential for pipeline
- Technology: 10-20% of revenue; drives product innovation
- Automotive: 4-6% of revenue; product cycles are long
- Consumer goods: 2-4% of revenue; incremental innovation
Key questions:
- Return on R&D: Is spending generating successful products?
- Competitive necessity: Must the company match peer spending to compete?
- Capitalisation practices: Are significant costs being capitalised rather than expensed?
R&D is an investment in future competitiveness. Companies that underinvest may see short-term profit benefits but long-term competitive decline. Evaluate R&D spending relative to industry requirements and track the success rate of R&D initiatives.
How it relates
Gross ProfitGross profit is revenue minus the cost of goods sold. It shows how much the company earns from its products or services before paying operating expenses, interest and taxes.−Research & Development−Selling, General & AdministrativeSelling, general and administrative expenses include sales, marketing, administrative staff and overhead. These costs support the business but are not directly tied to production.−Other Operating ExpensesOther operating expenses include smaller or miscellaneous costs related to running the business that don't fall into standard categories. They reduce operating income.=Operating IncomeOperating income is the profit the company makes from its normal business operations after paying operating expenses. It shows the performance of the core business before interest and taxes.
Where it fits
Research & Development÷RevenueRevenue is the total amount of money the company earned from selling its products or services. It is the top-line number that reflects the overall size of the company's business.→Operating Leverage